Evidence map›Paper›PMID 25627822›Full record

ArticleJournal of orthopaedic surgery and research2015

Warfarin cessation is non-essential in patients undergoing total knee arthroplasty--a case-control study.

Alfred Phillips, Michael Dan, Nathan Schaefer, Raymond Randle

Abstract read
In one paragraph

Article in Journal of orthopaedic surgery and research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Turkish journal of anaesthesiology and reanimation · 2019
    Article
  3. Observational
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alfred PhillipsGold Coast University Hospital, Southport, QLD, 4215, Australia. alfphillips@gmail.com.
Michael DanMaitland Hospital, Maitland, NSW, 2320, Australia. michael.dan@hnehealth.nsw.gov.au.
Nathan SchaeferGold Coast University Hospital, Southport, QLD, 4215, Australia. nathan.schaefer@health.qld.gov.au.
Raymond RandleJohn Flynn Private Hospital, Tugun, QLD, 4224, Australia. ddrrayra@bigpond.net.au.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWarfarinised patients frequently present for total knee arthroplasty (TKA). Current practice of heparin 'bridging' is potentially cumbersome and hazardous. The research question is if cessation of warfarin is necessary for TKA.

methodsThe study design was a retrospective case-control series of 61 warfarinised patients and 61 control patients undergoing TKA. TKA was performed by the senior author using a medial parapatellar approach without tourniquet. The target perioperative international normalised ratio (INR) for warfarinised patients was 2-2.2. Primary outcomes were changes in haemoglobin, transfusion requirements and complication rates.

resultsThere was no statistically significant difference between control and warfarin group in mean perioperative Hb (g/L) (pre-op 140 vs 141, day 0 115 vs 115, day 1 108 vs 111, P = 0.63), transfusion rates (14.75% vs 9.83%, P = 0.58), total complication rate (9.8% vs 9.8%, P = 0.75), demographics, range of motion or length of stay. There was a statistically significant higher use of the re-infusion drain in the warfarinised group (47.5% vs 24.6%, P = 0.014).

conclusionThis study supports the hypothesis that warfarin cessation is non-essential in patients undergoing TKA. This data is applicable to a patient group using re-infusion drains. Limitations of this study are typical of a small non-controlled observational study.

Indexed as

Arthroplasty, Replacement, KneeAnticoagulantsCase-Control StudiesHumansWarfarinAnticoagulantsWarfarin

Identifiers

PMID25627822
PMCPMC4314763

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.